248 related articles for article (PubMed ID: 23457487)
1. Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.
Yu J; Peng Y; Wu LC; Xie Z; Deng Y; Hughes T; He S; Mo X; Chiu M; Wang QE; He X; Liu S; Grever MR; Chan KK; Liu Z
PLoS One; 2013; 8(2):e55934. PubMed ID: 23457487
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia.
Shen N; Yan F; Pang J; Zhao N; Gangat N; Wu L; Bode AM; Al-Kali A; Litzow MR; Liu S
Clin Cancer Res; 2017 Oct; 23(20):6254-6266. PubMed ID: 28720666
[No Abstract] [Full Text] [Related]
3. Curcumin-Mediated Reversal of p15 Gene Promoter Methylation: Implication in Anti-Neoplastic Action against Acute Lymphoid Leukaemia Cell Line.
Sharma V; Jha AK; Kumar A; Bhatnagar A; Narayan G; Kaur J
Folia Biol (Praha); 2015; 61(2):81-9. PubMed ID: 26333125
[TBL] [Abstract][Full Text] [Related]
4. A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target.
Yan F; Shen N; Pang JX; Zhao N; Zhang YW; Bode AM; Al-Kali A; Litzow MR; Li B; Liu SJ
Leukemia; 2018 Apr; 32(4):865-873. PubMed ID: 28993705
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells.
Yan F; Shen N; Pang JX; Zhang YW; Rao EY; Bode AM; Al-Kali A; Zhang DE; Litzow MR; Li B; Liu SJ
Leukemia; 2017 Jun; 31(6):1434-1442. PubMed ID: 27885273
[TBL] [Abstract][Full Text] [Related]
6. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
Garzon R; Liu S; Fabbri M; Liu Z; Heaphy CE; Callegari E; Schwind S; Pang J; Yu J; Muthusamy N; Havelange V; Volinia S; Blum W; Rush LJ; Perrotti D; Andreeff M; Bloomfield CD; Byrd JC; Chan K; Wu LC; Croce CM; Marcucci G
Blood; 2009 Jun; 113(25):6411-8. PubMed ID: 19211935
[TBL] [Abstract][Full Text] [Related]
8. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
9. A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis.
Shen N; Yan F; Pang J; Wu LC; Al-Kali A; Litzow MR; Liu S
Oncotarget; 2014 Jul; 5(14):5494-509. PubMed ID: 25015109
[TBL] [Abstract][Full Text] [Related]
10. Modulation of DNA methylation by a sesquiterpene lactone parthenolide.
Liu Z; Liu S; Xie Z; Pavlovicz RE; Wu J; Chen P; Aimiuwu J; Pang J; Bhasin D; Neviani P; Fuchs JR; Plass C; Li PK; Li C; Huang TH; Wu LC; Rush L; Wang H; Perrotti D; Marcucci G; Chan KK
J Pharmacol Exp Ther; 2009 May; 329(2):505-14. PubMed ID: 19201992
[TBL] [Abstract][Full Text] [Related]
11. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.
Milutinovic S; Brown SE; Zhuang Q; Szyf M
J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453
[TBL] [Abstract][Full Text] [Related]
12. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
Sandoval JE; Huang YH; Muise A; Goodell MA; Reich NO
J Biol Chem; 2019 Mar; 294(13):4898-4910. PubMed ID: 30705090
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of FoxM1 transcription factor contributes to curcumin-induced inhibition of survival, angiogenesis, and chemosensitivity in acute myeloid leukemia cells.
Zhang JR; Lu F; Lu T; Dong WH; Li P; Liu N; Ma DX; Ji CY
J Mol Med (Berl); 2014 Dec; 92(12):1319-30. PubMed ID: 25179295
[TBL] [Abstract][Full Text] [Related]
15. Nobiletin Down-Regulates c-KIT Gene Expression and Exerts Antileukemic Effects on Human Acute Myeloid Leukemia Cells.
Chen PY; Chen YT; Gao WY; Wu MJ; Yen JH
J Agric Food Chem; 2018 Dec; 66(51):13423-13434. PubMed ID: 30507186
[TBL] [Abstract][Full Text] [Related]
16. Novel Curcumin Liposome Modified with Hyaluronan Targeting CD44 Plays an Anti-Leukemic Role in Acute Myeloid Leukemia in Vitro and in Vivo.
Sun D; Zhou JK; Zhao L; Zheng ZY; Li J; Pu W; Liu S; Liu XS; Liu SJ; Zheng Y; Zhao Y; Peng Y
ACS Appl Mater Interfaces; 2017 May; 9(20):16857-16868. PubMed ID: 28489348
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells.
Pang J; Shen N; Yan F; Zhao N; Dou L; Wu LC; Seiler CL; Yu L; Yang K; Bachanova V; Weaver E; Tretyakova NY; Liu S
Oncotarget; 2017 May; 8(21):34453-34467. PubMed ID: 28415607
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
Estève PO; Chin HG; Pradhan S
J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
[TBL] [Abstract][Full Text] [Related]
19. Preliminary study on the role of miR‑148a and DNMT1 in the pathogenesis of acute myeloid leukemia.
Wang XX; Zhang H; Li Y
Mol Med Rep; 2019 Apr; 19(4):2943-2952. PubMed ID: 30720097
[TBL] [Abstract][Full Text] [Related]
20. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
